The current study indicated that combined CK-19 and Ki-67 assessment can be used to indicate the risk for poor prognosis, including recurrence and distant metastasis in the first year following radical resection for HCC in HBV-positive patients, particularly in patients with an AFP concentration of <400 μg/L. Here, MKI67 is linked to hepatocellular carcinoma.